2m 2m 2m 2m 2m 2m 2m
KAIROS PHARMA (KAPA)
NYSE
$0.51-$0.005 (-0.96%)
Price as of Nov 12, 2026 8:05 AM EST- $1.7MMarket Cap
- -91.43%1-Year Change
- BiotechnologyIndustry
KAIROS PHARMA (KAPA)
$0.51-$0.005 (-0.96%)
KAPA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.51 | ||
Change | +$0.04 (+7.57%) | ||
Open | $0.50 | ||
High | $0.51 | ||
Low | $0.47 | ||
Previous Close | $0.47 | ||
Volume | 21,505 | ||
30-Day Average Volume | 119,736 | ||
1-Week Change | 4.12% | ||
1-Month Change | -37.07% | ||
1-Year Change | -91.43% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $4.5M | ||
Market Cap | $1.7M | ||
Enterprise Value | -$899,794.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.0M | ||
EBIT | $0.00 | ||
EBITDA | $22,000.00 | ||
Net Working Capital | $2.9M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 09/01/2026 | ||
Earnings & Revenue